4//SEC Filing
Anand Bhaskar 4
Accession 0001599298-24-000058
CIK 0001599298other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:47 PM ET
Size
5.8 KB
Accession
0001599298-24-000058
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-02+600,000→ 600,000 totalExercise: $3.85Exp: 2034-04-02→ Common Stock (600,000 underlying)
Footnotes (2)
- [F1]The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025. Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:47 PM ET
- Size
- 5.8 KB